Anna Esaki-Smith is an author and covers higher education. By now, the stereotypes about Generation Z ring familiar: They’re addicted to social media, hate emails, can’t be bothered to read ...

“Illumina has been supporting India for over a decade by providing access to genomic sequencing technologies, in particular next-generation sequencing, and building our presence and capability ...

In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.

The European Commission lacked oversight authority to examine the proposed sale of a cancer-detection company to biotech company Illumina, the court found.

“Illumina has been supporting India for over a decade by providing access to genomic sequencing technologies, in particular next-generation sequencing, and building our presence and capability in ...

In 2007, the next-generation sequencing technologies have ... John West, general manager of Illumina's DNA sequencing business unit and Kevin McKernan, an inventor of the Applied Biosystem's ...

BRUSSELS, Sept 3 (Reuters) - U.S. gene sequencing company Illumina (ILMN.O), opens new tab on Tuesday won its court fight against the European Union's investigation ...

Though Illumina said goodbye to Grail this past summer—after butting heads for years with antitrust regulators and activist investors, while enduring heavy fines and orders to split—the ...

(RTTNews) - Illumina, Inc. (ILMN) Tuesday announced that the 432 million euros fine imposed by the European Commission over GRAIL deal is no longer be payable after favorable verdict by the ...

SAN DIEGO, Aug. 27, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ ... qualitative in vitro diagnostic test that uses targeted next-generation sequencing to detect variants in 517 genes using ...

“Illumina has been supporting India for over a decade by providing access to genomic sequencing technologies, in particular next-generation sequencing, and building our presence and capability ...

"Illumina's newest distributable IVD kit for comprehensive genomic profiling and accompanying CDx enable another valuable clinical tool for the oncology community to match patients with targeted ...